Novartis’ Maalox acid relief OTC shortage causes concerns
1 June 2012
Novartis Nebraska plant closure, owing to the US Food and Drug Administration (FDA) raising serious concerns over manufacturing, has led to shortage of Maalox acid relief over the counter (OTC) drug in Canada.
The shortage is said to have come about at the Novartis’ plant manufacturing large number of OTC products, including Benefibre, Buckley’s, Excedrin, NeoCitran, Otrivin and Triaminic.
In March 2012, Novartis Canada said that there could be possible shortage of the number of OTC products and was not sure to when they would supply, owing to the upgrade going on at its manufacturing facility.
Novartis makes heartworm medication for pets too...Interceptor.
There was (is) a shortage on that too. Our vet is rationing it...3 months supply for current clients/patients, 1 month for non-clients. Our vet told us the shortage was coming, so we bought ahead.
Reminds me about the aspirin shortage in the former Soviet Union about the time it dissolved. They had one factory & some sort of disaster destroyed a significant part of it. I guess the FDA is our answer to the Soviet planned economy.